Keywords: NeuroSearch, Sophion, Biolin, Patch clam product, Huntexel, Hungtington's disease

NeuroSearch to get $7.8 million from sale of Sophion stake to Biolin Scientific

Article | 07 July 2011

Print This

Danish CNS drug developer NeuroSearch (NEUR: CO) is set to earn 40 million Danish kroner ($7.8 million) from the sales of its 30.1% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in